Research output per year
Research output per year
Fingerprint
Dive into the research topics where Angela Fonceca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Drug administration by inhalation in children
Fonceca, A., Ditcham, W., Everard, M. & Devadason, S., 2019, Kendig's Disorders of the Respiratory Tract in Children. Wilmot, R., Deterding, R., Li, A., Ratjen, F., Sly, P., Zar, H. & Bush, A. (eds.). 9th ed. Philadelphia, Pennsylvania: Elsevier, p. 257-271 16 p.Research output: Chapter in Book/Conference paper › Chapter › peer-review
2 Citations (Scopus) -
Accumulation mode particles and LPS exposure induce TLR-4 dependent and independent inflammatory responses in the lung
Fonceca, A. M., Zosky, G. R., Bozanich, E. M., Sutanto, E. N., Kicic, A., McNamara, P. S., Knight, D. A., Sly, P. D., Turner, D. J. & Stick, S. M., 22 Jan 2018, In: Respiratory Research. 19, 1, 15.Research output: Contribution to journal › Article › peer-review
Open Access15 Citations (Scopus) -
Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months
Fonceca, A. M., Chopra, A., Levy, A., Noakes, P. S., Poh, M. W. P., Bear, N. L., Prescott, S. & Everard, M. L., 1 Apr 2017, In: PLoS One. 12, 4, e0173738.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Web of Science) -
The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways
Trend, S., Fonceca, A. M., Ditcham, W. G., Kicic, A. & C.F., AREST., Nov 2017, In: Journal of Cystic Fibrosis. 16, 6, p. 663-670Research output: Contribution to journal › Review article › peer-review
Open Access19 Citations (Web of Science) -
Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF
McNamara, P. S., Fonceca, A. M., Howarth, D., Correia, J. B., Slupsky, J. R., Trinick, R. E., Al Turaiki, W., Smyth, R. L. & Flanagan, B. F., Jan 2013, In: Thorax. 68, 1, p. 76-81 6 p.Research output: Contribution to journal › Article › peer-review
44 Citations (Scopus)
-
Investigating RSV transmission in daycare centres
Blyth, C., Bhuiyan, M., Mahta, S. & Fonceca, A.
14/02/22 → 14/02/23
Project: Research
-
BridgeTech Fellowship - Commercial development of a biofilm disruptor
2/08/21 → 31/12/21
Project: Research
-
-
TPCHRF - Round 6 - A pre-clinical model for therapy testing and development in biofilm induced respiratory disease
Fonceca, A., Ditcham, W., Flematti, G., Everard, M., Devadason, S. & Berckmans, D.
Government of Western Australia, Department of Health
1/07/18 → 31/01/22
Project: Research
-
Identifying the Solution to the Challenge of Preventing the Annual Epidemics of RSV Bronchiolitis
1/07/15 → 30/06/16
Project: Research